#Canada #Toronto #Perimeter Medical #Imaging AI #Q2 2025 Results

Perimeter Medical Imaging AI Reports Strong Second Quarter 2025 Results

Perimeter Medical Imaging AI, Inc., a prominent player in the medical technology sector, recently shared their financial performance for the second quarter of 2025, marking a significant milestone in their ongoing journey. The company's impressive results reflect robust growth driven by innovative imaging technologies aimed at revolutionizing cancer surgery.

Financial Overview

In the second quarter, Perimeter generated approximately $506,000 in revenue, a remarkable increase of 105% when compared to Q2 2024. This growth trajectory continued as the company's total revenue for the first half of 2025 reached $1.1 million, representing a 25% surge over their full-year revenue for 2024. This increase underscores the rising demand for their flagship product, the Perimeter S-Series, which has now been utilized in imaging over 3,000 patients since its launch. Surgeons increasingly depend on this technology for its unique capability to provide intraoperative margin imaging at an unprecedented cellular level.

Strategic Partnerships and Product Development

Significant announcements were made during this quarter, including the deployment of the Perimeter S-Series device in collaboration with major healthcare entities such as HonorHealth in Arizona and Medical City Dallas Hospital in Texas. These partnerships highlight the trust placed in Perimeter's technology by leading healthcare providers, and further bolsters the company's market presence.

Looking ahead, Perimeter is excited about its upcoming B-Series OCT device, which integrates advanced artificial intelligence into the imaging process. Initial trials have shown promising outcomes, with statistically significant reductions in the presence of residual cancerous tissues during surgical procedures. This advancement positions Perimeter to potentially alter the surgical landscape by enhancing real-time decision-making capabilities for surgeons.

Continued Momentum and Cost Management

Despite a net loss of $3.9 million in Q2 2025, the company's leadership remains optimistic, citing the imminent rollout of their products and a diligent focus on operational cost management. By implementing strategic measures, Perimeter anticipates a 30% reduction in total operating expenses, starting in the third quarter.

Conference Call Invitation

To discuss these results in detail and provide insights into their future trajectory, Perimeter Medical Imaging AI will host a conference call today at 5 PM ET. Stakeholders and interested parties are encouraged to join the call through various access points.

About Perimeter Medical Imaging AI, Inc.

Headquartered in Toronto, Canada, with additional operations in Dallas, Texas, Perimeter Medical Imaging AI focuses on transforming cancer surgery through their award-winning advanced imaging technologies. Their FDA-cleared Perimeter S-Series OCT system exemplifies their commitment to providing real-time, high-resolution imaging solutions aimed at improving patient outcomes.

With continued innovation exemplified by the forthcoming Perimeter B-Series, the company is poised to maintain its position at the forefront of medical imaging technology. As they navigate through these advancements, Perimeter remains diligent in its commitment to addressing significant needs within the medical community, indicating a promising horizon not only for the company but ultimately for the patients they serve.